Koji Miyata

Tokushima, 7708503, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Adverse events of cetuximab sarotalocan in photoimmunotherapy: insights from the Japanese adverse drug event report database.

Adverse events of cetuximab sarotalocan in photoimmunotherapy: insights from the Japanese adverse drug event report database.

Journal: Cancer chemotherapy and pharmacology

Published: March 15, 2026

Muscle Atrophy-Related Adverse Events of Antidiabetic Drug Classes: A Pharmacovigilance Analysis Using VigiBase Data.

Muscle Atrophy-Related Adverse Events of Antidiabetic Drug Classes: A Pharmacovigilance Analysis Using VigiBase Data.

Journal: Journal of cachexia, sarcopenia and muscle

Published: June 17, 2025

Rifampicin in combination treatments for methicillin-resistant staphylococcal prosthetic joint infections: Claims database evaluation using a cohort of 52,588 hip arthroplasty patients.

Rifampicin in combination treatments for methicillin-resistant staphylococcal prosthetic joint infections: Claims database evaluation using a cohort of 52,588 hip arthroplasty patients.

Journal: International journal of clinical pharmacology and therapeutics

Published: May 21, 2025

Impact of antimicrobial stewardship interventions in pediatric populations on antimicrobial resistance: analysis of national claim and antimicrobial resistance surveillance data in Japan.

Impact of antimicrobial stewardship interventions in pediatric populations on antimicrobial resistance: analysis of national claim and antimicrobial resistance surveillance data in Japan.

Journal: The Journal of hospital infection

Published: April 23, 2025

Pharmacovigilance study for the identification of mogamulizumab-induced immune-related adverse events using a real-world database.

Pharmacovigilance study for the identification of mogamulizumab-induced immune-related adverse events using a real-world database.

Journal: The oncologist

Published: April 02, 2025

Flunitrazepam increases the risk of lamotrigine-induced cutaneous adverse reactions: Combined analysis of medical big data and clinical research.

Flunitrazepam increases the risk of lamotrigine-induced cutaneous adverse reactions: Combined analysis of medical big data and clinical research.

Journal: Psychiatry and clinical neurosciences

Published: February 12, 2025

Cardiovascular Toxicity Profile of Macrolides Investigated Using VigiBase Data: A Pharmacovigilance Study.

Cardiovascular Toxicity Profile of Macrolides Investigated Using VigiBase Data: A Pharmacovigilance Study.

Journal: Cardiovascular toxicology

Published: December 14, 2024

Clinical outcomes of flomoxef versus cefmetazole in hospitalized patients with urinary tract infections: combined retrospective analyses of two real-world databases and in vitro data.

Clinical outcomes of flomoxef versus cefmetazole in hospitalized patients with urinary tract infections: combined retrospective analyses of two real-world databases and in vitro data.

Journal: BMC medicine

Published: December 10, 2024

Evaluation of Interstitial Lung Disease Complications Caused by Biologic Agents Using a Spontaneous Adverse Drug Reaction Reporting Database.

Evaluation of Interstitial Lung Disease Complications Caused by Biologic Agents Using a Spontaneous Adverse Drug Reaction Reporting Database.

Journal: Pharmacology research & perspectives

Published: August 31, 2024

Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments.

Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 13, 2024

The Association between PDE5 Inhibitors and Aneurysm/Arterial Dissection:A Pharmacovigilance Study Using WHO Safety Database.

The Association between PDE5 Inhibitors and Aneurysm/Arterial Dissection:A Pharmacovigilance Study Using WHO Safety Database.

Journal: The journal of medical investigation : JMI

Published: May 12, 2024

Asciminib, a novel allosteric inhibitor of BCR-ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance.

Asciminib, a novel allosteric inhibitor of BCR-ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance.

Journal: Pharmacology research & perspectives

Published: January 24, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026